Immunovant Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	994.53	713.97	635.37	376.53	493.82	400.15
Cash & Short-Term Investments	994.53	713.97	635.37	376.53	493.82	400.15
Cash Growth	165.43%	12.37%	68.74%	-23.75%	23.41%	297.87%
Accounts Receivable	-	2.08	5.34	0.7	12.23	0.6
Other Receivables	1.64	0.43	0.17	0.19	0.63	0.55
Receivables	1.64	2.51	5.5	0.89	12.86	1.14
Prepaid Expenses	46.77	51.18	24.9	26.92	6.25	7.72
Total Current Assets	1,043	767.66	665.77	404.33	512.93	409.01
Property, Plant & Equipment	0.53	0.94	0.6	1.51	2.63	3.48
Other Long-Term Assets	8.92	7.62	-	-	-	-
Total Assets	1,052	776.22	666.37	405.84	515.56	412.49
Accounts Payable	8.62	17.66	7.16	1.35	18.63	2.43
Accrued Expenses	57.64	50.75	41.3	40.42	24.58	15.16
Current Portion of Leases	-	0.1	0.14	1.17	1.15	1.18
Other Current Liabilities	-	0.27	0.02	0.35	0.17	-
Total Current Liabilities	66.26	68.78	48.61	43.3	44.52	18.77
Long-Term Leases	-	-	-	0.05	1.22	2.24
Total Liabilities	66.26	68.78	48.61	43.34	45.74	21.01
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	2,582	1,945	1,442	927.98	824.8	590.43
Retained Earnings	-1,597	-1,240	-825.68	-566.35	-355.39	-198.66
Comprehensive Income & Other	1.2	1.46	1.91	0.85	0.4	-0.3
Shareholders' Equity	986.14	707.45	617.76	362.49	469.83	391.48
Total Liabilities & Equity	1,052	776.22	666.37	405.84	515.56	412.49
Total Debt	-	0.1	0.14	1.22	2.36	3.42
Net Cash (Debt)	994.53	713.87	635.23	375.31	491.45	396.73
Net Cash Growth	165.45%	12.38%	69.25%	-23.63%	23.88%	307.40%
Net Cash Per Share	5.74	4.71	4.60	3.05	4.48	4.52
Filing Date Shares Outstanding	203.53	170.92	146.05	130.41	116.51	97.98
Total Common Shares Outstanding	203.32	170.11	145.58	130.33	116.48	97.97
Working Capital	976.68	698.89	617.16	361.04	468.41	390.24
Book Value Per Share	4.85	4.16	4.24	2.78	4.03	4.00
Tangible Book Value	986.14	707.45	617.76	362.49	469.83	391.48
Tangible Book Value Per Share	4.85	4.16	4.24	2.78	4.03	4.00

Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q